Instead, we theorised that our analyses captured the progressive ‘endothelial-like switch’ of CD11c+ DCs within the tumour-conditioned media, so we termed these CD11c+CD45+ DCs expressing CD31 and CD34, and exhibiting morphological and molecular properties of endothelial cells, VLCs. The gene discussed is PECAM1; the disease is neoplasm.